SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Adaptimmune Ltd. Announces Exclusive License With Life Technologies on Proprietary Manufacturing Process for T Cell Therapy Using Its Modified T Cell Receptors